Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | M | $319K 10.4K sh | Sep 18, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Henderson KayaDirector | Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | Open-market sale | SELL | $4,961 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Baer MattDirector, Chief Executive Officer | Tax withholding | F | $338K 115.1K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $355K 12.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 19 | Sousa Mauad BrunoDirector | Derivative conversion | C | $1.53M 17.2K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 18 | Lo FrancisChief People Officer | Open-market sale · 10b5-1 plan | SELL | $3.01M 107.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Allen William TDirector | Option exercise | M | $17K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Rozenblat JennaPresident | Disposition to issuer | D | — 333 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Fitzpatrick JenniferCLO and Head of Program Mgmt. | Grant or award | A | — 28.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Allen William TDirector | Option exercise | M | $17K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | Option exercise | M | — 18.8K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Furner John R.Director, President & CEO | Open-market sale · 10b5-1 plan | SELL | $646K 6,045 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Rozenblat JennaPresident | Option exercise | M | — 417 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Furner John R.Director, President & CEO | Open-market sale · 10b5-1 plan | SELL | $754K 7,080 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Lin LaurenCLO, CCO and Secretary | Open-market sale · 10b5-1 plan | SELL | $46K 4,574 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Mancini AnthonySee Remarks | Open-market sale · 10b5-1 plan | SELL | $5,266 27 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 16 | Frisby Jeffry DDirector | Option exercise | M | $95K 4,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 16 | Polovin AndrewEVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $221K 2,951 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Wang LingkeDirector, President | Open-market sale · 10b5-1 plan | SELL | $4.31M 110.6K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 15 | Steward IanChief Revenue Officer | Tax withholding | F | $615K 12.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 15 | Blackman DonnaCHIEF FINANCIAL OFFICER | Tax withholding | F | $718K 8,747 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 14 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $19K 200 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | M | — 25.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 14 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $853 29 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $19K 606 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Feeley KevinCHIEF FINANCIAL OFFICER | Option exercise | M | — 7,197 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 14 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | M | — 10.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 13 | Kleiser Kirk E.Director | Option exercise | M | — 529 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Lumpkin AlexandraChief Legal Officer | Disposition to issuer | D | — 98 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | Baer MattDirector, Chief Executive Officer | Option exercise | M | — 61.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Greig Henry FDirector | Grant or award | A | — 988 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Cloonan MichaelDirector, President & CEO | Grant or award | A | — 109.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | Cloonan MichaelDirector, President & CEO | Grant or award | A | — 109.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | Frisby Jeffry DDirector | Option exercise | M | $36K 1,520 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Aufderhaar DavidChief Financial Officer | Option exercise | M | — 43.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $8,760 1,921 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | O'Connor CaseyChief Legal Officer | Option exercise | M | — 25.3K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Allen William TDirector | Option exercise | M | $23K 7,135 sh | Sep 18, 2026 traded Sep 16, 2026 |